ArticleJornal vascular brasileiro2026
Leiomyosarcoma of the inferior vena cava: a case report of a challenging diagnosis of abdominal pain.
Article in Jornal vascular brasileiro, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leiomyosarcoma of the inferior vena cava (IVC-LMS) is a rare malignant tumor, accounting for approximately 2% of all leiomyosarcomas, and predominantly affecting women over 50 years of age. Patients are often asymptomatic or present with nonspecific abdominal pain, which can hinder and delay diagnosis. We report the case of an 80-year-old male patient with a 3-month history of nonspecific abdominal pain. The diagnosis was established only intraoperatively, when the smooth muscle neoplasm initially suspected to originate from the duodenum was identified as an IVC-LMS. The patient underwent partial resection of the IVC with prosthetic interposition, followed by adjuvant chemoradiotherapy. Complete surgical resection remains the gold standard treatment of IVC-LMS and the only approach with curative potential. Prognosis largely depends on the stage at diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.